Check-Cap Ltd.

MBAI XNAS

Market Cap

13M

Short interest (May 15)

2.6%

Net Short (Jun 03 ): 0.1%

Borrow Fee

12.15%

↓ 26.7%

Available Shares

500K

↑ 22.7%

Price Chart

Company Overview

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.

Company Info

Exchange: NASDAQ
CIK: 0001610590
Asset Type: CS

Market Data

Market Cap: $12,909,699
Employees: 85
Status: Active

Short Interest

Current Borrow Fee 12.15%
Range: 12.15% - 12.95%
Available Shares 500K
Range: 400K - 500K

Recent Changes

Fee Change: ↑ 1.8%
Available Change: ↑ 5.6%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime